| BioBuzz has been connecting the life science workforce since 2009. We’ve built an expansive community in the Mid-Atlantic with a national readership that spans from Massachusettes to Florida, and New York to California. For our next chapter, we’re building a proprietary talent logistics model to help employers source and hire life science talent. Learn more. |
Bre Cameron has rejoined Amgen as the Veteran Program Manager, driven by her deep passion for supporting veterans. She firmly believes that “Employing veterans is not only the right thing to do, it is an investment in leadership, integrity, resilience, and so many other valuable attributes. Employing veterans makes a company stronger.”
Drawing from her own military background and professional expertise, Bre seamlessly integrates her recruitment and project management skills. She leverages her personal experiences of transitioning from the military to provide coaching, guidance, and advocacy for fellow veterans and military spouses aspiring to enter the biotech industry.
About Bre Cameron
Bre Cameron is a Navy veteran, who served from 2001 – 2006 in San Diego. She started her career in Talent Acquisition in 2011 working as a recruiter for various industries and clients. Bre joined Amgen as a contractor in 2017 as the Veteran Employment Program Manager and helped to build and manage their recruitment programs for veterans. In 2022 & 2023, she worked for Kite Pharma to build and lead their Veteran Hiring Program. As of March 2024, Bre has returned to Amgen to reprise her role as the Veteran Program manager. She has a Bachelor of Liberal Studies from Bowling Green State University and a Masters of Engaged Humanities & Depth Psychology from Pacifica Graduate Institute. A native of Northwest Ohio, Bre currently resides in Savannah, GA, and in her spare time enjoys traveling overseas, yoga, kayaking, making art and spending time at the beach on Tybee Island with her family and friends.
About Amgen
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Their belief—and the core of their strategy—is that innovative, highly differentiated medicines that offer significant clinical benefits in tackling serious diseases are not only beneficial for patients but also contribute to alleviating the social and economic burden of disease in society today.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology innovator since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
